Pediatric Rheumatology Online Journal
-
Publication Venue For
-
Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives..
21:39.
2023
-
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans..
20:113.
2022
-
Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry..
20:107.
2022
-
Pediatric rheumatologists' perspectives on diagnosis, treatment, and outcomes of Sjögren disease in children and adolescents..
20:79.
2022
-
Bilateral anterior and intermediate uveitis in SARS-CoV-2 associated multisystem inflammatory syndrome in a pediatric patient..
20:59.
2022
-
Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry..
20:50.
2022
-
Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis..
20:18.
2022
-
Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreat..
20:10.
2022
-
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE..
19:137.
2021
-
Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry..
19:131.
2021
-
Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis..
19:122.
2021
-
Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study..
19:62.
2021
-
Reproductive health needs of adolescent and young adult women with pediatric rheumatic diseases..
18:66.
2020
-
Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists..
18:57.
2020
-
Recurrent Henoch-Schönlein Purpura with bullous rash and pulmonary nodules..
18:40.
2020
-
Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry..
18:5.
2020
-
Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases..
17:72.
2019
-
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study..
17:43.
2019
-
Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise..
17:32.
2019
-
Health-related quality of life in children with inflammatory brain disease..
16:73.
2018
-
Inpatient burden of juvenile dermatomyositis among children in the United States..
16:70.
2018
-
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis..
16:65.
2018
-
Autoimmune phenotype with type I interferon signature in two brothers with ADA2 deficiency carrying a novel CECR1 mutation..
15:67.
2017
-
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America..
15:50.
2017
-
A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities..
15:31.
2017
-
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months..
15:30.
2017
-
Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans..
15:23.
2017
-
Missed opportunities for timely diagnosis of pediatric lupus in South Africa: a qualitative study..
15:14.
2017
-
Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits..
14:54.
2016
-
Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study..
14:46.
2016
-
Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016..
14 Suppl 1:41.
2016
-
Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry..
14:14.
2016
-
Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry..
14:9.
2016
-
The deficiency of adenosine deaminase type 2-results of therapeutic intervention
2015
-
Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature..
13:13.
2015
-
Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type..
12:38.
2014
-
MRI guided wire localization muscle biopsy in a child with juvenile dermatomyositis.
11.
2013
-
Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology..
10:31.
2012
-
Developing a standardized approach to the assessment of pain in children and youth presenting to pediatric rheumatology providers: a Delphi survey and consensus conference process followed by feasibility testing..
10:7.
2012
-
Research priorities in pediatric rheumatology: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus..
6:5.
2008
-
Involvement of dendritic cells in autoimmune diseases in children.
5.
2007
-
Engaging patients and parents to improve mental health intervention for youth with rheumatological disease.
2021